Jorge Matías‐Guiu

Multimodal neuroimaging in post-COVID syndrome and correlation with cognition

María Díez‐Cirarda, Miguel Yus, Natividad Gómez‐Ruiz et al. · Brain · 2022 · 191 citations · Full text

Neuropsychology, White Matter, Brain Lesion +23

Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study

Cristina Delgado‐Alonso, María Valles‐Salgado, Alfonso Delgado‐Álvarez et al. · Journal of Psychiatric Research · 2022 · 168 citations · Full text

Neuropsychological Functioning, Neuropsychology, Cognitive Dysfunction +3

Efficacy and Tolerability in Migraine Prophylaxis of Flunarizine in Reduced Doses: A Comparison with Propranolol 160 Mg Daily

H-C Diener, Jorge Matías‐Guiu, Emily Hartung et al. · Cephalalgia · 2002 · 118 citations

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study

Maarten Timmers, Johannes Streffer, Alberto Russu et al. · Alzheimer s Research & Therapy · 2018 · 106 citations · Full text

Comparative Diagnostic Accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for Screening of Alzheimer Disease

Jordi A. Matías‐Guiu, María Valles‐Salgado, Teresa Rognoni et al. · Dementia and Geriatric Cognitive Disorders · 2017 · 105 citations